Literature DB >> 25722925

Target specificity of the CRISPR-Cas9 system.

Xuebing Wu1, Andrea J Kriz2, Phillip A Sharp3.   

Abstract

The CRISPR-Cas9 system, naturally a defense mechanism in prokaryotes, has been repurposed as an RNA-guided DNA targeting platform. It has been widely used for genome editing and transcriptome modulation, and has shown great promise in correcting mutations in human genetic diseases. Off-target effects are a critical issue for all of these applications. Here we review the current status on the target specificity of the CRISPR-Cas9 system.

Entities:  

Keywords:  CRISPR; Cas9; genome engineering; off-targets; target specificity

Year:  2014        PMID: 25722925      PMCID: PMC4338555          DOI: 10.1007/s40484-014-0030-x

Source DB:  PubMed          Journal:  Quant Biol        ISSN: 2095-4689


  82 in total

1.  Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

Authors:  F Ann Ran; Patrick D Hsu; Chie-Yu Lin; Jonathan S Gootenberg; Silvana Konermann; Alexandro E Trevino; David A Scott; Azusa Inoue; Shogo Matoba; Yi Zhang; Feng Zhang
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

Review 2.  CRISPR-based adaptive and heritable immunity in prokaryotes.

Authors:  John van der Oost; Matthijs M Jore; Edze R Westra; Magnus Lundgren; Stan J J Brouns
Journal:  Trends Biochem Sci       Date:  2009-07-29       Impact factor: 13.807

3.  Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells.

Authors:  Xuebing Wu; David A Scott; Andrea J Kriz; Anthony C Chiu; Patrick D Hsu; Daniel B Dadon; Albert W Cheng; Alexandro E Trevino; Silvana Konermann; Sidi Chen; Rudolf Jaenisch; Feng Zhang; Phillip A Sharp
Journal:  Nat Biotechnol       Date:  2014-04-20       Impact factor: 54.908

4.  Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells.

Authors:  Lior Nissim; Samuel D Perli; Alexandra Fridkin; Pablo Perez-Pinera; Timothy K Lu
Journal:  Mol Cell       Date:  2014-05-15       Impact factor: 17.970

5.  Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system.

Authors:  Baohui Chen; Luke A Gilbert; Beth A Cimini; Joerg Schnitzbauer; Wei Zhang; Gene-Wei Li; Jason Park; Elizabeth H Blackburn; Jonathan S Weissman; Lei S Qi; Bo Huang
Journal:  Cell       Date:  2013-12-19       Impact factor: 41.582

6.  Zinc Finger Targeter (ZiFiT): an engineered zinc finger/target site design tool.

Authors:  Jeffry D Sander; Peter Zaback; J Keith Joung; Daniel F Voytas; Drena Dobbs
Journal:  Nucleic Acids Res       Date:  2007-05-25       Impact factor: 16.971

7.  RNA-guided editing of bacterial genomes using CRISPR-Cas systems.

Authors:  Wenyan Jiang; David Bikard; David Cox; Feng Zhang; Luciano A Marraffini
Journal:  Nat Biotechnol       Date:  2013-01-29       Impact factor: 54.908

8.  Improving CRISPR-Cas nuclease specificity using truncated guide RNAs.

Authors:  Yanfang Fu; Jeffry D Sander; Deepak Reyon; Vincent M Cascio; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-01-26       Impact factor: 54.908

9.  RNA-guided gene activation by CRISPR-Cas9-based transcription factors.

Authors:  Pablo Perez-Pinera; D Dewran Kocak; Christopher M Vockley; Andrew F Adler; Ami M Kabadi; Lauren R Polstein; Pratiksha I Thakore; Katherine A Glass; David G Ousterout; Kam W Leong; Farshid Guilak; Gregory E Crawford; Timothy E Reddy; Charles A Gersbach
Journal:  Nat Methods       Date:  2013-07-25       Impact factor: 28.547

10.  A guide RNA sequence design platform for the CRISPR/Cas9 system for model organism genomes.

Authors:  Ming Ma; Adam Y Ye; Weiguo Zheng; Lei Kong
Journal:  Biomed Res Int       Date:  2013-10-03       Impact factor: 3.411

View more
  93 in total

1.  Cas9 Variants Expand the Target Repertoire in Caenorhabditis elegans.

Authors:  Ryan T Bell; Becky X H Fu; Andrew Z Fire
Journal:  Genetics       Date:  2015-12-17       Impact factor: 4.562

2.  Dynamics of Cas10 Govern Discrimination between Self and Non-self in Type III CRISPR-Cas Immunity.

Authors:  Ling Wang; Charlie Y Mo; Michael R Wasserman; Jakob T Rostøl; Luciano A Marraffini; Shixin Liu
Journal:  Mol Cell       Date:  2018-11-29       Impact factor: 17.970

Review 3.  Chromatin regulation at the frontier of synthetic biology.

Authors:  Albert J Keung; J Keith Joung; Ahmad S Khalil; James J Collins
Journal:  Nat Rev Genet       Date:  2015-02-10       Impact factor: 53.242

4.  Mechanisms of improved specificity of engineered Cas9s revealed by single-molecule FRET analysis.

Authors:  Digvijay Singh; Yanbo Wang; John Mallon; Olivia Yang; Jingyi Fei; Anustup Poddar; Damon Ceylan; Scott Bailey; Taekjip Ha
Journal:  Nat Struct Mol Biol       Date:  2018-04-05       Impact factor: 15.369

5.  Easy In Vitro Synthesis of Optimised Functioning Reporter mRNA from Common eGFP Plasmid.

Authors:  Gustavo Torres de Souza; Rafaela Chitarra Rodrigues Hell; Jéssica Fernanda da Silva Souza; Luiz Sérgio de Almeida Camargo
Journal:  Mol Biotechnol       Date:  2018-10       Impact factor: 2.695

6.  Massively Parallel Biophysical Analysis of CRISPR-Cas Complexes on Next Generation Sequencing Chips.

Authors:  Cheulhee Jung; John A Hawkins; Stephen K Jones; Yibei Xiao; James R Rybarski; Kaylee E Dillard; Jeffrey Hussmann; Fatema A Saifuddin; Cagri A Savran; Andrew D Ellington; Ailong Ke; William H Press; Ilya J Finkelstein
Journal:  Cell       Date:  2017-06-29       Impact factor: 41.582

Review 7.  How specific is CRISPR/Cas9 really?

Authors:  Henriette O'Geen; Abigail S Yu; David J Segal
Journal:  Curr Opin Chem Biol       Date:  2015-10-24       Impact factor: 8.822

8.  Improved nearest-neighbor parameters for the stability of RNA/DNA hybrids under a physiological condition.

Authors:  Dipanwita Banerjee; Hisae Tateishi-Karimata; Tatsuya Ohyama; Saptarshi Ghosh; Tamaki Endoh; Shuntaro Takahashi; Naoki Sugimoto
Journal:  Nucleic Acids Res       Date:  2020-12-02       Impact factor: 16.971

9.  Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors.

Authors:  Luqman Jubair; Sora Fallaha; Nigel A J McMillan
Journal:  Mol Ther       Date:  2019-08-29       Impact factor: 11.454

10.  Lentivirus pre-packed with Cas9 protein for safer gene editing.

Authors:  J G Choi; Y Dang; S Abraham; H Ma; J Zhang; H Guo; Y Cai; J G Mikkelsen; H Wu; P Shankar; N Manjunath
Journal:  Gene Ther       Date:  2016-04-07       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.